Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mark H. Stefaniak is active.

Publication


Featured researches published by Mark H. Stefaniak.


Green Chemistry | 2008

Green chemistry tools to influence a medicinal chemistry and research chemistry based organisation

Kim Alfonsi; Juan Colberg; Peter J. Dunn; Thomas Lee Fevig; Sandra M. Jennings; Timothy Allen Johnson; H. Peter Kleine; Craig Knight; Mark A. Nagy; David Austen Perry; Mark H. Stefaniak

Influencing and improving the environmental performance of a large multi-national pharmaceutical company can be achieved with the help of electronic education tools, backed up by site champions and strong site teams. This paper describes the development of two of those education tools.


Tetrahedron Letters | 1980

Nucleophilic SN2 displacements on penicillin-6- and cephalosporin-7- triflates; 6β-iodopenicillanic acid, a new β-lactamase inhibitor

John Edward Glyn Kemp; Michael D. Closier; Subramanian Narayanaswami; Mark H. Stefaniak

Abstract Triflate or nonaflate esters of alkyl 6α (or β) hydroxypenicillanates are substituted (with inversion) by the soft nucleophiles iodide, bromide, chloride, azide, arylselenoxide, 1 thiocyanate, thiols, and thiolacids; carbon nucleophiles fail. Methoxide (hard) attacks the lactam bond, opening both rings to give a known 11 1,4 thiazine. Iodide substitutes 7α-trifloxycephalosporins, giving 7β-iodocephalosporins.


Bioorganic & Medicinal Chemistry Letters | 1999

A new class of selective and potent inhibitors of neuronal nitric oxide synthase.

John A. Lowe; Weimin Qian; Robert A. Volkmann; Steven D. Heck; Jolanta Nowakowski; Robert B. Nelson; Charles E. Nolan; Dane Liston; Karen M. Ward; Stevin H. Zorn; Celeste Johnson; Michelle Vanase; W. Stephen Faraci; Kimberly A. Verdries; James Baxter; Shawn D. Doran; Martin Sanders; Mike Ashton; Peter John Whittle; Mark H. Stefaniak

The synthesis and SAR of a series of 6-(4-(substituted)phenyl)-2-aminopyridines as inhibitors of nitric oxide synthase are described. Compound 3a from this series shows potent and selective inhibition of the human nNOS isoform, with pharmacokinetics sufficient to provide in vivo inhibition of nNOS activity.


Heterocycles | 2006

Synthesis of 5-Heterocyclic Substituted Quinazolin-4-ones via 2-Aminobenzonitrile Derivatives

M. Jonathan Fray; Paul Allen; Paul R. Bradley; Clare E. Challenger; Michael D. Closier; Tim J. Evans; Mark L. Lewis; John Paul Mathias; Carly L. Nichols; Yvonne M. Po-Ba; Hayley Snow; Mark H. Stefaniak; Hannah V. Vuong

Two routes to prepare a series of six 5-heterocyclic substituted 2-chloro-7-methoxyquinazolin-4-ones are described, where the heterocycle is a substituted or unsubstituted 1-pyrazolyl, 5-pyrazolyl or 2-thiazolyl group. Both routes proceeded via key 2-aminobenzonitrile intermediates.


Tetrahedron Letters | 1979

Penicillin and cephalosporin sulphoximines

John Edward Glyn Kemp; Michael D. Closier; Mark H. Stefaniak

Abstract Penicillin N -cyanosulphoximines are obtained by permanganate oxidation of the sulphilimines. Phthalimidosulphoximines are obtained from penicillin or cephalosporin sulphoxides are phthalimidonitrene (from N -aminophthalimide with lead tetraacetate).


Journal of Medicinal Chemistry | 2011

Design and Synthesis of Inhaled P38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease.

David Simon Millan; Mark Edward Bunnage; Jane L. Burrows; Kenneth John Butcher; Peter G. Dodd; Tim J. Evans; David Fairman; Samantha J. Hughes; Iain Kilty; Arnaud Lemaitre; Russell Andrew Lewthwaite; Axel Mahnke; John Paul Mathias; James Philip; Robert T. Smith; Mark H. Stefaniak; Michael Yeadon; Christopher Phillips


Journal of Medicinal Chemistry | 1989

2(1H)-Quinolinones with cardiac stimulant activity. 2. Synthesis and biological activities of 6-(N-linked, five-membered heteroaryl) derivatives

Colin T. Alabaster; Andrew Simon Bell; Simon F. Campbell; Peter M. Ellis; Christopher G. Henderson; David Stuart Morris; David Anthony Roberts; Keith S. Ruddock; Gillian Mary Ryder Samuels; Mark H. Stefaniak


Journal of Medicinal Chemistry | 1988

2(1H)-Quinolinones with cardiac stimulant activity. 1. Synthesis and biological activities of (six-membered heteroaryl)-substituted derivatives

Colin T. Alabaster; Andrew Simon Bell; Simon F. Campbell; Peter M. Ellis; Christopher G. Henderson; David Anthony Roberts; Keith S. Ruddock; Gillian Mary Ryder Samuels; Mark H. Stefaniak


Archive | 2003

Quinazoline compounds useful in therapy

Julian Blagg; Michael Jonathan Fray; Mark L. Lewis; John Paul Mathias; Mark H. Stefaniak; Alan Stobie


Journal of Medicinal Chemistry | 1995

Novel Antagonists of Platelet-Activating Factor. 2. Synthesis and Structure-Activity Relationships of Potent and Long-Acting Heterofused [1,5]Benzodiazepine and [1,4]Diazepine Derivatives of 1-Phenyl-2-methylimidazo[4,5-c]pyridine

Michael Jonathan Pfizer C. Fray; David John Bull; K. Cooper; M. J. Parry; Mark H. Stefaniak

Collaboration


Dive into the Mark H. Stefaniak's collaboration.

Researchain Logo
Decentralizing Knowledge